{"id":56809,"date":"2026-03-03T09:55:43","date_gmt":"2026-03-03T08:55:43","guid":{"rendered":"https:\/\/editing.capitalmind.com\/?post_type=deals&#038;p=56809"},"modified":"2026-03-03T10:23:35","modified_gmt":"2026-03-03T09:23:35","slug":"cession-de-vievepharm-a-zenex-animal-health-india-soutenue-par-multiples-equity","status":"publish","type":"deals","link":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-vievepharm-a-zenex-animal-health-india-soutenue-par-multiples-equity\/","title":{"rendered":"Cession de VievePharm \u00e0 Zenex Animal Health India soutenue par Multiples Equity"},"content":{"rendered":"\n<p><strong>Investec a conseill\u00e9 VievePharm dans le cadre de la cession transfrontali\u00e8re \u00e0 Zenex, soci\u00e9t\u00e9 bas\u00e9e en Inde et soutenue par Multiples Equity<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">A propos du deal<\/h2>\n\n\n\n<p>VievePharm, sp\u00e9cialiste n\u00e9erlandais de la nutrition animale, a rejoint le groupe Zenex Animal Health India Private Limited (\u00ab Zenex \u00bb), soci\u00e9t\u00e9 indienne leader dans le domaine de la sant\u00e9 animale.<\/p>\n\n\n\n<p>VievePharm et Zenex sont compl\u00e9mentaires, en effet les deux entreprises reposent sur les m\u00eames principes : <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>des produits fond\u00e9s sur la science, <\/li>\n\n\n\n<li>des normes de qualit\u00e9 rigoureuses, et <\/li>\n\n\n\n<li>des relations clients \u00e0 long terme. <\/li>\n<\/ul>\n\n\n\n<p>L&rsquo;expertise de VievePharm en mati\u00e8re de nutrition pr\u00e9ventive et de technologie bolus compl\u00e8te le portefeuille th\u00e9rapeutique plus large de Zenex, tandis que le rayonnement mondial, le r\u00e9seau de distribution et la plateforme de fabrication de Zenex offrent \u00e0 VievePharm la possibilit\u00e9 de se d\u00e9velopper \u00e0 l&rsquo;international et de continuer \u00e0 innover dans le domaine de la nutrition animale pr\u00e9ventive.<\/p>\n\n\n\n<p>Ensemble, elles forment une entreprise de sant\u00e9 animale comp\u00e9titive \u00e0 l&rsquo;\u00e9chelle mondiale, disposant d&rsquo;un portefeuille complet, d&rsquo;une port\u00e9e g\u00e9ographique \u00e9tendue et d&rsquo;une forte ambition pour tirer parti des importantes opportunit\u00e9s de croissance \u00e0 venir.<\/p>\n\n\n\n<p><strong>\u00c0 propos de VievePharm<\/strong><\/p>\n\n\n\n<p>Fond\u00e9e en 2006 et bas\u00e9e \u00e0 Enter, aux Pays-Bas, VievePharm est une entreprise sp\u00e9cialis\u00e9e dans la nutrition animale qui est devenue l&rsquo;un des principaux producteurs europ\u00e9ens de bolus et de compl\u00e9ments alimentaires. Le portefeuille de la soci\u00e9t\u00e9 se concentre sur les solutions de sant\u00e9 pr\u00e9ventive pour le b\u00e9tail, avec des produits con\u00e7us pour am\u00e9liorer la sant\u00e9, la fertilit\u00e9 et la productivit\u00e9 des animaux.<\/p>\n\n\n\n<p><strong>\u00c0 propos de Zenex<\/strong><\/p>\n\n\n\n<p>Zenex exploite un portefeuille diversifi\u00e9 couvrant le b\u00e9tail, la volaille et les animaux de compagnie, et propose des produits synth\u00e9tiques et naturels pour r\u00e9pondre aux besoins th\u00e9rapeutiques et nutritionnels. Avec un chiffre d&rsquo;affaires de plus de 100 millions d&rsquo;euros, Zenex a \u00e9tabli une forte pr\u00e9sence nationale en Inde et une pr\u00e9sence internationale croissante dans plus de 15 pays de la r\u00e9gion MENA (<em>Middle\u00a0East\u00a0and\u00a0North\u00a0Africa<\/em>), de l&rsquo;ASEAN (<em>Association\u00a0of\u00a0Southeast\u00a0Asian\u00a0Nations<\/em>) et de l&rsquo;Europe de l&rsquo;Est.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Notre r\u00f4le<\/h2>\n\n\n\n<p>Investec a conseill\u00e9 VievePharm tout au long du processus de cession jusqu&rsquo;\u00e0 la conclusion de la transaction, notamment dans les domaines suivants :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Organisation d&rsquo;un processus d&rsquo;ench\u00e8res concurrentiel<\/li>\n\n\n\n<li>Structuration de la transaction<\/li>\n\n\n\n<li>N\u00e9gociation des prix<\/li>\n\n\n\n<li>Gestion du processus de <em>due diligence<\/em><\/li>\n\n\n\n<li>Coordination de la phase de documentation juridique<\/li>\n<\/ul>\n\n\n\n<p>Les relations \u00e9tablies entre Investec India et Zenex ont jou\u00e9 un r\u00f4le essentiel dans la facilitation de cette transaction.<\/p>\n\n\n\n<p><strong>Cette transaction souligne les solides ant\u00e9c\u00e9dents d&rsquo;Investec dans le secteur mondial de la sant\u00e9 animale et refl\u00e8te la grande exp\u00e9rience que notre \u00e9quipe d\u00e9di\u00e9e \u00e0 la sant\u00e9 animale apporte \u00e0 des mandats transfrontaliers complexes.<\/strong><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Investec a conseill\u00e9 VievePharm dans le cadre de la cession transfrontali\u00e8re \u00e0 Zenex, soci\u00e9t\u00e9 bas\u00e9e en Inde et soutenue par&#8230;<\/p>\n","protected":false},"featured_media":0,"template":"","dt":[3757,3762,3766],"sector":[3732,3768],"dealtype":[3706],"clienttype":[3729,3699],"class_list":["post-56809","deals","type-deals","status-publish","hentry","dt-cross-border-fr","dt-financial-investor-involved-fr","dt-landmark-deal-fr","sector-agroalimentaire-fr","sector-healthcare-fr","dealtype-cession-fr","clienttype-entrepreneurs-fr","clienttype-mid-market-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cession de VievePharm \u00e0 Zenex Animal Health India soutenue par Multiples Equity | Investec Business Advisory<\/title>\n<meta name=\"description\" content=\"Investec a conseill\u00e9 VievePharm dans le cadre de la cession transfrontali\u00e8re \u00e0 Zenex, soci\u00e9t\u00e9 bas\u00e9e en Inde et soutenue par Multiples Equity\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-vievepharm-a-zenex-animal-health-india-soutenue-par-multiples-equity\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cession de VievePharm \u00e0 Zenex Animal Health India soutenue par Multiples Equity | Investec Business Advisory\" \/>\n<meta property=\"og:description\" content=\"Investec a conseill\u00e9 VievePharm dans le cadre de la cession transfrontali\u00e8re \u00e0 Zenex, soci\u00e9t\u00e9 bas\u00e9e en Inde et soutenue par Multiples Equity\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-vievepharm-a-zenex-animal-health-india-soutenue-par-multiples-equity\/\" \/>\n<meta property=\"og:site_name\" content=\"Investec Business Advisory\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T09:23:35+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/deals\\\/cession-de-vievepharm-a-zenex-animal-health-india-soutenue-par-multiples-equity\\\/\",\"url\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/deals\\\/cession-de-vievepharm-a-zenex-animal-health-india-soutenue-par-multiples-equity\\\/\",\"name\":\"Cession de VievePharm \u00e0 Zenex Animal Health India soutenue par Multiples Equity | Investec Business Advisory\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#website\"},\"datePublished\":\"2026-03-03T08:55:43+00:00\",\"dateModified\":\"2026-03-03T09:23:35+00:00\",\"description\":\"Investec a conseill\u00e9 VievePharm dans le cadre de la cession transfrontali\u00e8re \u00e0 Zenex, soci\u00e9t\u00e9 bas\u00e9e en Inde et soutenue par Multiples Equity\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/deals\\\/cession-de-vievepharm-a-zenex-animal-health-india-soutenue-par-multiples-equity\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/deals\\\/cession-de-vievepharm-a-zenex-animal-health-india-soutenue-par-multiples-equity\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/deals\\\/cession-de-vievepharm-a-zenex-animal-health-india-soutenue-par-multiples-equity\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cession de VievePharm \u00e0 Zenex Animal Health India soutenue par Multiples Equity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/\",\"name\":\"Investec Business Advisory\",\"description\":\"Investec Business Advisory\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#organization\",\"name\":\"Capitalmind Investec\",\"url\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/Logo_Investec_cmjn_6.jpg\",\"contentUrl\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/Logo_Investec_cmjn_6.jpg\",\"width\":1120,\"height\":1121,\"caption\":\"Capitalmind Investec\"},\"image\":{\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/capitalmind---corporate-finance-advisory\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC4bVt7iNejh8tGT6Qfa9R4w\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cession de VievePharm \u00e0 Zenex Animal Health India soutenue par Multiples Equity | Investec Business Advisory","description":"Investec a conseill\u00e9 VievePharm dans le cadre de la cession transfrontali\u00e8re \u00e0 Zenex, soci\u00e9t\u00e9 bas\u00e9e en Inde et soutenue par Multiples Equity","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-vievepharm-a-zenex-animal-health-india-soutenue-par-multiples-equity\/","og_locale":"fr_FR","og_type":"article","og_title":"Cession de VievePharm \u00e0 Zenex Animal Health India soutenue par Multiples Equity | Investec Business Advisory","og_description":"Investec a conseill\u00e9 VievePharm dans le cadre de la cession transfrontali\u00e8re \u00e0 Zenex, soci\u00e9t\u00e9 bas\u00e9e en Inde et soutenue par Multiples Equity","og_url":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-vievepharm-a-zenex-animal-health-india-soutenue-par-multiples-equity\/","og_site_name":"Investec Business Advisory","article_modified_time":"2026-03-03T09:23:35+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-vievepharm-a-zenex-animal-health-india-soutenue-par-multiples-equity\/","url":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-vievepharm-a-zenex-animal-health-india-soutenue-par-multiples-equity\/","name":"Cession de VievePharm \u00e0 Zenex Animal Health India soutenue par Multiples Equity | Investec Business Advisory","isPartOf":{"@id":"https:\/\/www.investec.com\/advisory\/fr\/#website"},"datePublished":"2026-03-03T08:55:43+00:00","dateModified":"2026-03-03T09:23:35+00:00","description":"Investec a conseill\u00e9 VievePharm dans le cadre de la cession transfrontali\u00e8re \u00e0 Zenex, soci\u00e9t\u00e9 bas\u00e9e en Inde et soutenue par Multiples Equity","breadcrumb":{"@id":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-vievepharm-a-zenex-animal-health-india-soutenue-par-multiples-equity\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-vievepharm-a-zenex-animal-health-india-soutenue-par-multiples-equity\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-vievepharm-a-zenex-animal-health-india-soutenue-par-multiples-equity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.investec.com\/advisory\/fr\/"},{"@type":"ListItem","position":2,"name":"Cession de VievePharm \u00e0 Zenex Animal Health India soutenue par Multiples Equity"}]},{"@type":"WebSite","@id":"https:\/\/www.investec.com\/advisory\/fr\/#website","url":"https:\/\/www.investec.com\/advisory\/fr\/","name":"Investec Business Advisory","description":"Investec Business Advisory","publisher":{"@id":"https:\/\/www.investec.com\/advisory\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.investec.com\/advisory\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.investec.com\/advisory\/fr\/#organization","name":"Capitalmind Investec","url":"https:\/\/www.investec.com\/advisory\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.investec.com\/advisory\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.investec.com\/advisory\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","contentUrl":"https:\/\/www.investec.com\/advisory\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","width":1120,"height":1121,"caption":"Capitalmind Investec"},"image":{"@id":"https:\/\/www.investec.com\/advisory\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/capitalmind---corporate-finance-advisory","https:\/\/www.youtube.com\/channel\/UC4bVt7iNejh8tGT6Qfa9R4w"]}]}},"_links":{"self":[{"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/deals\/56809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/deals"}],"about":[{"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/types\/deals"}],"wp:attachment":[{"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/media?parent=56809"}],"wp:term":[{"taxonomy":"dt","embeddable":true,"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/dt?post=56809"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/sector?post=56809"},{"taxonomy":"dealtype","embeddable":true,"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/dealtype?post=56809"},{"taxonomy":"clienttype","embeddable":true,"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/clienttype?post=56809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}